QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Résumé Extracto Full Text PDF Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Articles Ahead of Print [Order Reprint] Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rex, D. K Search for Related Content PubMed PubMed Citation Articles by Rex, D. K

GASTROENTEROLOGY

Dosing Considerations in the Use of Sodium Phosphate Bowel Preparations for Colonoscopy

Director of Endoscopy, Indiana University Hospital, Indiana University Medical Center, #4100, 550 North University Blvd., Indianapolis, IN 46202, fax 317/274-5449, drex{at}iupui.edu

Reprints: Dr. Rex

OBJECTIVE: To review dosing considerations and other treatment recommendations to maximize the efficacy, tolerability, and safety of sodium phosphate (NaP) preparations.

DATA SOURCES: Literature was accessed through PubMed (1990-May 2007) and abstracts from scientific meetings.

STUDY SELECTION AND DATA EXTRACTION: English-language publications including clinical trials and case reports were evaluated. Recent reports assessing newer bowel preparations containing reduced doses of NaP were reviewed to evaluate efficacy, tolerability, and safety.

DATA SYNTHESIS: Among commonly administered bowel preparations for colonoscopy, NaP preparations are generally more effective and better tolerated compared with polyethylene glycol electrolyte lavage solution regimens. However, NaP preparations are contraindicated in specific patient populations, and clinicians must use effective screening mechanisms to select proper patients to receive NaP preparation for colonoscopy. Recently, cases of renal failure in patients with previously normal renal function have been reported after NaP preparation for colonoscopy, heightening concerns about the safety of these agents. Newer products contain reduced doses of NaP and may improve the safety and tolerability of NaP purgatives without compromising efficacy of colon cleansing. In addition, accumulating clinical data and/or rationale support split dosing of NaP products, wide intervals between doses, and aggressive hydration before and during bowel preparation and after the colonoscopy procedure.

CONCLUSIONS: Safe administration of NaP products requires rigorous attention to dosing considerations and other treatment recommendations, including administration of minimally effective doses of NaP, split-dosing schedules, and aggressive hydration.

Key Words: bowel purgatives, sodium phosphate

Published Online, July 24, 2007. www.theannals.com, DOI 10.1345/aph.1K206

This article has been cited by other articles:

				G. Lichtenstein Bowel preparations for colonoscopy: A review Am. J. Health Syst. Pharm., January 1, 2009; 66(1): 27 - 37. [Abstract] [Full Text] [PDF]

				E. C. Heher, S. O. Thier, H. Rennke, and B. D. Humphreys Adverse Renal and Metabolic Effects Associated with Oral Sodium Phosphate Bowel Preparation Clin. J. Am. Soc. Nephrol., September 1, 2008; 3(5): 1494 - 1503. [Abstract] [Full Text] [PDF]